The retrieval gave partial results. I'll complete this answer comprehensively from both retrieved content and established medical knowledge.
Neutrophil to Lymphocyte Ratio (NLR)
What Is It?
The NLR is a simple, inexpensive inflammatory biomarker derived from a routine Complete Blood Count (CBC) with differential — a test already ordered in virtually every clinical setting.
Formula:
NLR = Absolute Neutrophil Count ÷ Absolute Lymphocyte Count
| Category | NLR Value |
|---|
| Normal (healthy adults) | 1.0 – 3.0 |
| Mildly elevated | 3.0 – 5.0 |
| Significantly elevated | > 5.0 |
| Critically elevated | > 10.0 |
Why Is It Relevant?
NLR reflects the balance between innate immunity (neutrophils) and adaptive/regulatory immunity (lymphocytes). When this balance shifts:
- ↑ NLR = systemic stress, infection, inflammation, immune dysregulation, or malignancy
- ↓ NLR = sometimes seen in autoimmune states or viral infections
This makes NLR a proxy for the host's inflammatory and immune status — without any additional cost beyond the CBC.
Clinical Applications in Routine Diagnostic Practice
1. Infection & Sepsis
- NLR > 5 raises suspicion for bacterial infection; > 10 suggests severe sepsis or septic shock
- Useful as a quick triage tool in emergency settings before culture results return
- Higher NLR correlates with increased ICU admission risk and mortality in sepsis
- Complements procalcitonin and CRP for infection severity stratification
2. Cardiovascular Disease
- Elevated NLR is an independent predictor of:
- Acute Myocardial Infarction (AMI) severity and mortality
- Heart failure — higher NLR = worse prognosis
- Stroke outcomes
- Post-MI NLR > 5 is associated with major adverse cardiac events (MACE)
3. Oncology — Diagnosis & Prognosis
- Pre-treatment NLR is a validated prognostic marker across multiple cancers:
- Colorectal, gastric, pancreatic, lung, hepatocellular carcinoma (HCC), breast, bladder
- In HCC, lower NLR is associated with better outcomes after sorafenib and immunotherapy (CheckMate 040 trial showed patients progressing on nivolumab had significantly higher NLR than disease-control patients)
- Elevated NLR (> 3–5, threshold varies by tumor type) predicts shorter overall survival and progression-free survival
- Can help select patients for aggressive vs. palliative intent therapy
4. Surgical Risk Stratification
- Pre-operative NLR predicts post-operative complications, anastomotic leaks, wound infections
- NLR > 5 preoperatively is a marker of increased surgical morbidity
5. COVID-19 and Viral Illnesses
- During COVID-19, NLR emerged as a powerful predictor of ICU admission, mechanical ventilation need, and mortality
- NLR > 3.13 on admission correlated with severe disease
6. Autoimmune & Inflammatory Conditions
- Used to monitor disease activity in Rheumatoid Arthritis, IBD (Crohn's/UC), SLE
- Elevated NLR tracks flares; declining NLR reflects therapeutic response
7. Metabolic Conditions
- Elevated NLR correlates with insulin resistance, NAFLD, metabolic syndrome, and Type 2 Diabetes severity
How to Use It in Practice — A Clinical Algorithm
CBC with Differential ordered
↓
Calculate NLR = ANC ÷ ALC
↓
┌─────────────────────────────────────────────┐
│ NLR < 3 → Likely normal / low risk │
│ NLR 3–5 → Mild inflammation / monitor │
│ NLR 5–10 → Significant — investigate │
│ (infection, malignancy, ACS) │
│ NLR > 10 → Severe systemic stress — │
│ sepsis, advanced cancer, │
│ critical illness │
└─────────────────────────────────────────────┘
Advantages Over Other Inflammatory Markers
| Feature | NLR | CRP | Procalcitonin | ESR |
|---|
| Cost | Free (from CBC) | Low | High | Low |
| Turnaround | Immediate | 1–2 hrs | 2–4 hrs | Hours |
| Bacterial vs viral differentiation | Moderate | Poor | Good | Poor |
| Cancer prognosis | Strong | Moderate | Poor | Poor |
| Cardiac risk | Strong | Good | Moderate | Poor |
| Trend monitoring | Yes | Yes | Yes | Yes |
Important Limitations
- Not disease-specific — a high NLR tells you something is wrong, not exactly what
- Results affected by: corticosteroid use (raises neutrophils, lowers lymphocytes → falsely elevates NLR), recent surgery, physiological stress, smoking
- Cutoff values vary by condition and study population — no single universal threshold
- Should always be interpreted in clinical context alongside history, examination, and other investigations
- Lymphopenia from non-inflammatory causes (e.g., HIV, chemotherapy) can falsely elevate NLR
Summary
The NLR is a zero-cost, immediately available, clinically powerful tool extracted from a CBC that every clinician already orders. Its strength lies in risk stratification — identifying patients who are sicker than they appear, flagging malignancy-related immunosuppression, and predicting outcomes across infections, cardiac events, cancers, and surgical procedures. Its limitation is non-specificity, so it must always accompany — not replace — clinical judgment.